Serial QuantiFERON TB-2G Testing Over a Four-year Period in Healthcare Workers at a City Hospital

1. Yamauchi Y. Tuberculosis risk of female nurses based on the Tuberculosis Surveillance Data. Kekkaku 74: 819-821, 1999 (in Japanese).

2. Moran-Mendoza O, Marion SA, Elwood K, et al. Tuberculin skin test size and risk of tuberculosis development: a large population-based study in contacts. Int J Tuberc Lung Dis 11: 1014-1020, 2007.

3. Menzies D. What does tuberculin reactivity after Bacille Calmette-Guerin vaccination tell us? Clin Infect Dis 31 (Suppl 3): S71-S74, 2000.

4. Pai M, Riley LW, Colford JM Jr. Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 4: 761-776, 2004.

5. Dheda K, Udwadia ZF, Huggett JF, et al. Utility of the antigen-specific interferon-γ assay for the management of tuberculosis. Curr Opin Pulm Med 11: 195-202, 2005.

6. CDC. Guidelines for preventing the transmission of <i>Mycobacterium tuberculosis</i> in health-care settings. MMWR 54: 1-141, 2005.

7. Vinton P, Mihrshahi S, Johnson P, et al. Comparison of QuantiFERON-TB Gold In-Tube Test and tuberculin skin test for identification of latent Mycobacterium tuberculosis infection in healthcare staff and association between positive test results and known risk factors for infection. Infect Control Hosp Epidemiol 30: 215-221, 2009.

8. Pai M, Joshi R, Dogra S, et al. Serial Testing of Health Care Workers for Tuberculosis Using Interferon-&gamma; Assay. Am J Respir Crit Care Med 174: 349-355, 2006.

9. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 161: S221-S247, 2000.

10. Ministry of Health, Labour and Welfare in Japan. Number of registered patients with active TB and the rate of prevalence in 2010. Available from: http://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou03/dl/10.html

11. Menzies D, Joshi R, Pai M. Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis 11: 593-605, 2007.

12. Seidler A, Nienhaus A, Diel R. Review of epidemiological studies on the occupational risk of tuberculosis in low-incidence areas. Respiration 72: 431-446, 2005.

13. Nahid P, Pai M, Hopewell PC. Advances in the diagnosis and treatment of tuberculosis. Proc Am Thorac Soc 3: 103-110, 2006.

14. Diel R, Loddenkemper R, Meywald-Walter K, Gottschalk R, Nienhaus A. Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold In Tube Assay, and T-Spot. TB test in contact investigations for tuberculosis. Chest 135: 1010-1018, 2009.

15. Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-&gamma; release assays for detecting active TB: a meta-analysis. Chest 137: 952-968, 2010.

16. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole blood IFN-&alpha; assay for the development of active tuberculosis disease after recent infection with <i>Mycobacterium tuberculosis</i>. Am J Respir Crit Care Med 177: 1164-1170, 2008.

17. Diel R, Loddenkemper R, Niemann S, Meywald-Walter K, Nienhaus A. Negative and positive predictive value of a whole-blood Interferon-&gamma; release assay for developing active tuberculosis: an update. Am J Respir Crit Care Med 183: 88-95, 2011.

18. Mori T, Sakatani M, Yamagishi F, et al. Specific detection of tuberculosis infection: an interferon-&gamma;-based assay using new antigens. Am J Respir Crit Care Med 170: 59-64, 2004.

19. Hotta K, Ogura T, Nishii K, et al. Whole blood Interferon-gamma assay for baseline tuberculosis screening among Japanese healthcare students. PLoS One 2: e803, 2007.

20. Nakajima Y, Ogata H, Yoshiyama T, et al. Results of repeated QFT-2G checkings at two-year interval and their comparison with TST results introduced into infection control program for staffs working at a hospital with isolation wards for tuberculosis. Kekkaku 83: 445-450, 2008 (in Japanese).

21. Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, Mori T. Screening for tuberculosis infection using whole-blood interferon-&gamma; and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol 27: 442-448, 2006.

22. Mori T, Harada N, Higuchi K, Sekiya Y, Uchimura K, Shimao T. Waning of the specific interferon-gamma response after years of tuberculosis infection. Int J Tuberc Lung Dis 11: 1021-1025, 2007.

23. Suzuki K, Onozaki I, Shimura A, et al. QuantiFERON-TB-2^nd Generation in the elderly person. Kekkaku 79: 200, 2004 (in Japanese).

24. Leyten EM, Mulder B, Prins C, et al. Use of enzyme-linked immunospot assay with <i>Mycobacterium tuberculosis</i>-specific peptides for diagnosis of recent infection with <i>M. tuberculosis</i> after accidental laboratory exposure. J Clin Microbiol 44: 1197-1201, 2006.

25. Anderson ST, Williams AJ, Brown JR, et al. Transmission of <i>Mycobacterium tuberculosis</i> undetected by tuberculin skin testing. Am J Respir Crit Care Med 173: 1038-1042, 2006.

26. Veerapathran A, Joshi R, Goswami K, et al. T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data. PLoS ONE 3: e1850, 2008.

27. Fox BD, Kramer MR, Mor Z, et al. The QuantiFERON-TB-GOLD assay for tuberculosis screening in healthcare workers: a cost-comparison analysis. Lung 187: 413-419, 2009.

28. de Perio MA, Tsevat J, Roselle GA, Kralovic SM, Eckman MH. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers. Arch Intern Med 169: 179-187, 2009.

29. Ito K. Efficiency of periodic QuantiFERON-TB GOLD test in hospital nurse. Kekkaku 84: 709-712, 2009 (in Japanese).

30. Harada N. Interpretation of QFT results in several contact investigations. Kekkaku 85: 595-599, 2010 (in Japanese).